Companies/US/JSPR

JASPER THERAPEUTICS, INC.

Last · NasdaqCM$0.555-0.0152 (-2.67%)stale · yahoo · 63h ago
Vol 620.1K ≈ 310.7K
Market cap$18.47M33.3M sh
P/E · TTM-0.5fwd -0.2 · eps -1.04 · loss
Beta—vs S&P 500
Div yield0.00%annual · TTM
52w range
$0.315$2.69
Volume335.8Ksession

Issuer

Legal nameJASPER THERAPEUTICS, INC.
HQUnited States (US)
ListingUS JSPR
ISINUS4718712023
SectorHealthcare
IndustryDrugs (Biotechnology)
SIC2836
CurrencyUSD
Entity registrysec:0001788028
CIK0001788028
Websitewww.jaspertherapeutics.com
Employees22
AddressJasper Therapeutics, Inc. 2200 Bridge Parkway 94065, Redwood City
Loading chart…

Upcoming earnings

1 event
8:00 PM UTC+1
Period
Sep 2026
Est. EPS
−$0.56
Est. revenue
0
View upcoming earnings →

Press & signals

3 of 5 recent
  • Satelight

    Zafira–A dual-mode language bridging Python agility and native C safety

  • GlobeNewswire

    Jasper Therapeutics Announces Commencement of an Offer to Purchase Outstanding Warrants

  • GlobeNewswire

    Jasper Therapeutics Announces Key Regulatory and Clinical Appointments

The rest of this company's wire — with summaries and source links — is part of Pro.

See plans

Documents

FormReporting forFiledFlags
8-KCurrent Report (8-K)
—2026-10-070
8-K/AAmended Current Report (8-K/A)
—2026-10-050
8-KCurrent Report (8-K)
—2026-10-050
8-K/AAmended Current Report (8-K/A)
—2026-10-010
8-KCurrent Report (8-K)
—2026-09-280
Showing 5 of 9 filings